Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHODH | Q02127 | 3/20 | 0.41 |
| ▸ | ANO1 | Q5XXA6 | 2/20 | 0.37 |
| ▸ | MALT1 | Q9UDY8 | 3/20 | 0.36 |
| ▸ | DGAT2 | Q96PD7 | 2/20 | 0.34 |
| ▸ | KIF18A | Q8NI77 | 2/20 | 0.33 |
| ▸ | NTRK1 | P04629 | 3/20 | 0.33 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.33 |
| ▸ | PDE4A | P27815 | 1/20 | 0.33 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.33 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.33 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.33 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4162046 | 0.93 | DHODH (0.39) | DHODHANO1MALT1DGAT2NTRK1 | |
| SCHEMBL10280352 | 0.92 | DHODH (0.40) | DHODHMALT1DGAT2 | |
| SCHEMBL10280397 | 0.91 | DHODH (0.39) | DHODHMALT1DGAT2NTRK1TRPV1 | |
| SCHEMBL4160602 | 0.90 | DHODH (0.40) | DHODHANO1MALT1PDE4APDE4B | |
| SCHEMBL12912066 | 0.89 | DHODH (0.44) | DHODHMALT1TRPV1 | |
| Chlorantraniliprole SCHEMBL29363261 | 0.88 | DHODH (0.44) | DHODHMALT1NTRK1TRPV1 | |
| Chlorantraniliprole SCHEMBL29551 | 0.88 | DHODH (0.44) | DHODHMALT1NTRK1TRPV1 | |
| SCHEMBL3204989 | 0.88 | DHODH (0.40) | DHODHMALT1KIF18ANTRK1 | |
| SCHEMBL902720 | 0.88 | DHODH (0.46) | DHODHMALT1TRPV1 | |
| SCHEMBL950846 | 0.87 | DHODH (0.44) | DHODHMALT1NTRK1TRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090133318-A1 | Anthranilamide insecticides | E. I. DU PONT DE NEMOURS AND COMPANY | 2009-05-28 | — | — | US | claimed |
| EP-1812421-A2 | ANTHRANILAMIDE INSECTICIDES | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2007-08-01 | — | — | EP | claimed |
| WO-2006055922-A2 | ANTHRANILAMIDE INSECTICIDES | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2006-05-26 | — | — | WO | claimed |
| EP-2564706-A1 | Anthranilamide insecticides | E. I. du Pont de Nemours and Company (US) | 2013-03-06 | — | — | EP | disclosed |
| US-20090133318-A1 | Anthranilamide insecticides | E. I. DU PONT DE NEMOURS AND COMPANY | 2009-05-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090133318-A1 | Anthranilamide insecticides | C3AR1, C5, C1S | DHODH 1809/4885ANO1 1229/4885MALT1 1842/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.